| Financial Year |
March 31 2023 |
| Monetary Funds |
2,041,579,577.87 |
| Held-for-trading Financial Assets |
225,763,159.73 |
| Notes Receivable |
554,900,678.69 |
| Accounts Receivable |
3,030,009,451.02 |
| Advances to Suppliers |
544,573,013.91 |
| Other Receivables |
1,551,937,468.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,934,514,819.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
172,928,840.40 |
| Other Current Assets |
917,304,490.99 |
| Total Current Assets |
17,890,449,265.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
74,910,031.03 |
| Long-term Equity Investment |
39,873,388.85 |
| Investment Properties |
219,052,097.83 |
| Fixed Assetes |
2,233,261,899.48 |
| Under-construction Projects |
980,096,841.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,633,378,005.14 |
| R&D expenses |
-- |
| Goodwill |
707,040,405.51 |
| Long-Term Deferred and Prepaid Expenses |
25,090,792.41 |
| Deferred Income Tax Assets |
256,003,023.77 |
| Other Non-Current Assets |
329,465,390.19 |
| Sub-Total of Non-Current Assets |
7,948,560,541.14 |
| Total Assets |
25,839,009,806.73 |
| Short-Term Loans |
1,009,889,540.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
434,350,842.24 |
| Accounts Payable |
4,246,133,660.65 |
| Accounts Received In Advance |
87,887,645.69 |
| Employee Compensation Payable |
56,636,732.89 |
| Taxes Payable |
120,978,256.05 |
| Interest Payable |
-- |
| Dividend Payable |
23,293,148.85 |
| Other payables |
148,307,998.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
580,190,862.34 |
| Other Current Liabilities |
168,825,431.29 |
| Sub-Total of Current Liabilities |
13,288,908,946.88 |
| Long-term Loans |
2,175,621,640.79 |
| Bonds Payable |
1,777,807,969.01 |
| Long-Term Accounts Payable |
176,884,639.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
80,666,705.62 |
| Deferred Income Tax Liabilities |
74,484,067.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,657,367,662.26 |
| Total Liabilities |
17,946,276,609.14 |
| Paid-In Capital(Or Share Stock) |
1,079,840,484.00 |
| Capital Surplus |
540,083,825.13 |
| Surplus Reserve |
542,869,281.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,222,552,509.45 |
| Minority Stockholder's Interest |
235,073,168.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,657,660,028.77 |
| Owner's Equity（Stockholder's Equity） |
7,892,733,197.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,839,009,806.73 |
